Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
5,889.50
-6.75(-0.11%)
Dow Futures
43,126.00
-51.00(-0.12%)
Nasdaq Futures
20,485.25
-34.25(-0.17%)
Russell 2000 Futures
2,250.30
-5.20(-0.23%)
Crude Oil
70.54
-0.02(-0.03%)
Gold
2,737.00
-1.90(-0.07%)

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

1.3200

+0.1700

(+14.78%)

At close: 04:00PM EDT

1.3199

-0.00

(-0.01%)

After hours:

07:56PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	85.96M
Enterprise Value	57.46M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	10.28
Price/Book (mrq)	N/A
Enterprise Value/Revenue	7.64
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	2.36
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	2.1200
52 Week Low ³	0.6500
50-Day Moving Average ³	1.1599
200-Day Moving Average ³	1.2848

Share Statistics

Avg Vol (3 month) ³	677.12k
Avg Vol (10 day) ³	2.66M
Shares Outstanding ⁵	74.75M
Implied Shares Outstanding ⁶	N/A
Float ⁸	69.16M
% Held by Insiders ¹	7.39%
% Held by Institutions ¹	26.33%
Shares Short (Sep 30, 2024) ⁴	261.22k
Short Ratio (Sep 30, 2024) ⁴	0.65
Short % of Float (Sep 30, 2024) ⁴	0.37%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	0.35%
Shares Short (prior month Aug 30, 2024) ⁴	335.17k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-8,433.33%

Management Effectiveness

Return on Assets (ttm)	-44.05%
Return on Equity (ttm)	N/A

Income Statement

Revenue (ttm)	7.52M
Revenue Per Share (ttm)	0.11
Quarterly Revenue Growth (yoy)	-91.20%
Gross Profit (ttm)	N/A
EBITDA	-25.66M
Net Income Avi to Common (ttm)	-33.46M
Diluted EPS (ttm)	-0.5000
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	29.36M
Total Cash Per Share (mrq)	0.39
Total Debt (mrq)	47.59M
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	5.07
Book Value Per Share (mrq)	-0.38

Cash Flow Statement

Operating Cash Flow (ttm)	-19.11M
Levered Free Cash Flow (ttm)	-17.5M